BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7560436)

  • 1. Correlation of lesional skin corneometry values with serum E-selectin levels and disease severity in patients affected by plaque-type psoriasis: recovery after effective therapy.
    Carducci M; Mussi A; Bonifati C; Tomaselli R; Onorati MT; Trento E; Ameglio F
    J Dermatol; 1995 Jul; 22(7):475-9. PubMed ID: 7560436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of data normalization for age on the correlations between corneometric values and serum molecule levels in plaque-type psoriatic patients.
    Carducci M; Mussi A; Bonifati C; Pietravalle M; Alemanno L; Fazio M; Ameglio F
    Acta Derm Venereol; 1997 Mar; 77(2):110-4. PubMed ID: 9111819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial.
    Bhushan M; Bleiker TO; Ballsdon AE; Allen MH; Sopwith M; Robinson MK; Clarke C; Weller RP; Graham-Brown RA; Keefe M; Barker JN; Griffiths CE
    Br J Dermatol; 2002 May; 146(5):824-31. PubMed ID: 12000379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble E-selectin serum levels correlate with disease activity in psoriatic patients.
    Szepietowski J; Wasik F; Bielicka E; Nockowski P; Noworolska A
    Clin Exp Dermatol; 1999 Jan; 24(1):33-6. PubMed ID: 10233646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a randomized controlled trial.
    Liu M; Li X; Chen XY; Xue F; Zheng J
    Dermatol Ther; 2015; 28(6):373-82. PubMed ID: 26286610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring of sE-selectin serum levels in three different dermatoses].
    D'Auria L; Bonifati C; Mussi A; Ameglio F
    Clin Ter; 1998; 149(921):49-52. PubMed ID: 9621489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin level is significantly elevated in lesional skin of patients with psoriasis.
    El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE
    Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis.
    Mussi A; Bonifati C; Carducci M; D'Agosto G; Pimpinelli F; D'Urso D; D'Auria L; Fazio M; Ameglio F
    J Biol Regul Homeost Agents; 1997; 11(3):115-8. PubMed ID: 9498161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of sELAM-1 in psoriatic patients correlates with disease activity.
    Krasowska D; Pietrzak A; Lecewicz-Torun B
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):140-2. PubMed ID: 10343943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
    Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
    Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cutaneous surface parameters in psoriatic patients.
    Cannavò SP; Guarneri F; Giuffrida R; Aragona E; Guarneri C
    Skin Res Technol; 2017 Feb; 23(1):41-47. PubMed ID: 27270565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
    Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Giuliano A; Sabato S; Stramazzotti D; Gulini E; Dusi D; De Blasio S; Fabris G; Offidani A
    Int J Immunopathol Pharmacol; 2009; 22(2):371-7. PubMed ID: 19505391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity.
    Bonifati C; Mussi A; Carducci M; Pittarello A; D'Auria L; Venuti A; Bagnato A; Salani D; Fazio M; Ameglio F
    Acta Derm Venereol; 1998 Jan; 78(1):22-6. PubMed ID: 9498021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profiles during infliximab monotherapy in psoriatic arthritis.
    Mastroianni A; Minutilli E; Mussi A; Bordignon V; Trento E; D'Agosto G; Cordiali-Fei P; Berardesca E
    Br J Dermatol; 2005 Sep; 153(3):531-6. PubMed ID: 16120138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.
    Thaçi D; Blauvelt A; Reich K; Tsai TF; Vanaclocha F; Kingo K; Ziv M; Pinter A; Hugot S; You R; Milutinovic M
    J Am Acad Dermatol; 2015 Sep; 73(3):400-9. PubMed ID: 26092291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
    Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients.
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    Am J Clin Dermatol; 2017 Aug; 18(4):583-590. PubMed ID: 28342016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.